Homoharringtonine
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Homoharringtonine, covering 2013-01-23 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study [EARLY_Phase 1]